IMS – The Impact of Biosimilar Competition (2015)

1 November 2015

Report

This document sets out to describe the effects on price, […]

EGA-EBG Considerations on WHO’s BQ Proposal – Suzette Kox, WHO INN Open Session with Stakeholders, Geneva, 13 October 2015 (PPT)

13 October 2015

Policy

IGES Report: Value of Generic Medicines – Health Economics Study, Berlin, 5 October 2015

5 October 2015

Report

To consult the infographics, please click here.

EGA Vision 2015

19 July 2015

Report

To view the full report, please click here.

Investing in People Centred Health Service Delivery – Paul Cornes, Riga Health Conference – How to Improve Health Systems Through Technology? 29-30 June 2015, Riga, Latvia (PPT)

29 June 2015

Policy

Launch of European Value Added medicines (EVA), a new EGA sector group, will deliver efficiency

12 June 2015

Policy

Brussels – The European Generic and Biosimilar medicines Association (EGA) announced […]

IMS Health 2015: The Role of Generic Medicines in Sustaining Healthcare Systems: A European Perspective, June 2015

1 June 2015

Report

To view the full report, click here To view the […]

Universal Access to Health 2015 Event – 5 May 2015 – Video Playlist

5 May 2015

Video

EMA & Biosimilar Update: Trends from marketing authorisation applications, scientific advice procedures and policies – Peter Richardson, EBG Biosimilars 2015, London (PPT)

24 April 2015

Policy

The Science of Extrapolation – Martina Weise, EBG Biosimilars 2015, London (PPT)

23 April 2015

Policy

To view the full presentation, please click here. Part I […]